PEAR Therapeutics
Digital/ Views & Analysis/ Views and analysis
Digital therapeutics: a new frontier of medicine
Ben Hargreaves
digital therapeutics, Digital Therapeutics Alliance, Limbix, PEAR Therapeutics, Rock Health
0 Comment
Digital health firm Pear goes public, raising $175 million
Phil Taylor
digital, digital health, financing, PEAR Therapeutics, SPAC, Substance Use Disorder
0 Comment
Pear claims breakthrough tag for alcohol use disorder DTx
Phil Taylor
alcohol use disorder, Breakthrough Device Designation, digital, digital health, digital therapeutics, PEAR Therapeutics
0 Comment
Digital therapeutic cuts opioid use disorder care costs, says study
Phil Taylor
digital, digital health, opioid use disorder, opioids, PEAR Therapeutics
0 Comment
NIH starts trial of Pear, Chess apps for opioid use disorder
Phil Taylor
Chess Health, digital, digital health, digital therapeutics, opioid crisis, opioid use disorder, PEAR Therapeutics
0 Comment
DTx company Pear shapes public listing with $1.6bn SPAC merger
Phil Taylor
digital, digital health, digital therapeutics, financing, PEAR Therapeutics, SPAC
0 Comment
Ohio is third state to fund Pear’s digital therapeutics to tackle addiction
Richard Staines
digital therapeutics, opioids, PEAR Therapeutics
0 Comment
Digital therapies for opioid use disorder need more data, says ICER
Phil Taylor
Chess Health Solutions, digital, digital therapeutics, DynamiCare Health, opioid crisis, opioid use disorder, PEAR Therapeutics
0 Comment